RxDoctor Payments DataLook up a doctor →

Julia Gomez, MD

Family Medicine · Nashville, TNNPI 1174576599

Payments from drug & device makers

$17,997in general payments, 2019–2025

Across 962 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$2K
  • AbbVie$2K
  • Amgen$1K
  • GSK$1K
  • Pfizer$1K
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$17,69698%
  • Education$3012%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk103$2,031
AstraZeneca47$1,729
AbbVie(2 entities)114$1,651
Amgen(2 entities)82$1,470
GSK59$1,214
Pfizer93$1,180
Lilly USA, LLC66$1,113
Astellas Pharma US Inc37$908
Merck46$596
Boehringer Ingelheim20$460
Novartis26$460
Exact Sciences18$397
Esperion Therapeutics, Inc.17$382
Abbott17$381
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC20$368
Takeda Pharmaceuticals U.S.A., Inc.23$339
Biohaven Pharmaceuticals, Inc.17$335
Kowa Pharmaceuticals America, Inc.18$290
Teva Pharmaceuticals USA, Inc.8$223
Tris Pharma Inc12$220
Johnson & Johnson13$216
Biohaven Pharmaceutical Holding Company Ltd.10$199
Otsuka America Pharmaceutical, Inc.8$158
Corium, LLC5$98
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$84
Daiichi Sankyo Inc.4$81
Gilead5$79
Endo Pharmaceuticals Inc.5$77
Adlon Therapeutics L.p.4$74
Endogastric Solutions, Inc2$73
Amarin Pharma, Inc.4$71
Nestle Healthcare Nutrition Inc.4$61
Boston Scientific2$58
CMP Pharma, Inc.3$55
Vanda Pharmaceuticals Inc.3$55
Dynavax Technologies Corporation2$52
Hologic Inc1$51
Idorsia Pharmaceuticals US Inc3$51
Shield Therapeutics Inc3$47
Bausch Health US, LLC2$44
Axsome Therapeutics, Inc.2$42
Mylan Pharmaceuticals Inc.3$41
Currax Pharmaceuticals LLC3$40
Inspire Medical Systems, Inc.1$40
Xeris Pharmaceuticals, Inc.2$38
Eisai Inc.2$37
Mayne Pharma Commercial LLC2$36
Ironshore Pharmaceuticals Inc.2$33
Amneal Pharmaceuticals LLC2$32
Jazz Pharmaceuticals Inc.1$31
Hologic Sales And Service, LLC2$29
Sunovion Pharmaceuticals Inc.1$21
Neurocrine Biosciences, Inc.1$20
Phathom Pharmaceuticals, Inc.1$20
Bayer1$19
Almatica Pharma LLC1$19
Phadia US Inc.1$17
Ultragenyx Pharmaceutical Inc.1$15
Lundbeck LLC1$13
Genentech USA, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,997 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$87,820
Medicare patients
231
Services billed
808

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin74$75,934
OzempicSemaglutide48$61,625
EliquisApixaban64$50,790
MounjaroTirzepatide31$42,252
TrulicityDulaglutide26$35,321
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$28,013
MyrbetriqMirabegron37$17,176
FarxigaDapagliflozin Propanediol13$16,816
Breo ElliptaFluticasone/Vilanterol25$13,838
Divalproex Sodium ErDivalproex Sodium26$4,017
SynthroidLevothyroxine Sodium42$3,941
Atorvastatin Calcium263$3,462
Rosuvastatin Calcium188$2,685
Duloxetine Hcl70$2,507
Metoprolol Succinate116$2,201

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,113$77,57357 claims
Boehringer IngelheimJardiance$460$75,93474 claims
Novo NordiskOzempic$2,031$61,62548 claims
PfizerEliquis$1,180$50,79064 claims
GSKTrelegy Ellipta, Breo Ellipta$1,214$41,85254 claims
Astellas Pharma US IncMyrbetriq$908$17,17637 claims
AstraZenecaFarxiga$1,729$16,81613 claims
AbbVieSynthroid$1,651$3,94142 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$32$2,175246 claims
Almatica Pharma LLCSertraline Hcl$19$994122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →